Matches in Wikidata for { <http://www.wikidata.org/entity/Q113933570> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q113933570 description "clinical trial" @default.
- Q113933570 description "ensayo clínico" @default.
- Q113933570 description "ensayu clínicu" @default.
- Q113933570 description "klinisch onderzoek" @default.
- Q113933570 description "клінічне випробування" @default.
- Q113933570 description "تجربة سريرية" @default.
- Q113933570 description "临床试验" @default.
- Q113933570 name "S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers" @default.
- Q113933570 type Item @default.
- Q113933570 label "S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers" @default.
- Q113933570 prefLabel "S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers" @default.
- Q113933570 P1132 Q113933570-813F8627-A0EB-4124-8770-DDF88CC111BA @default.
- Q113933570 P1476 Q113933570-BE0DEBDD-0A02-477F-8766-B62E49BD2BD0 @default.
- Q113933570 P17 Q113933570-A666C7B5-35A3-4645-9CA5-FD05C9BFC0F4 @default.
- Q113933570 P17 Q113933570-D54AC011-1CA9-41FF-9E8C-6A55A4942145 @default.
- Q113933570 P2899 Q113933570-C45FD7F0-E124-4D83-A2C3-BDE0D9A15556 @default.
- Q113933570 P3098 Q113933570-516927FD-7809-4AC9-BCF9-A45EF3CDB4A8 @default.
- Q113933570 P31 Q113933570-D2331437-507D-414D-91E6-BC9B17B03B1B @default.
- Q113933570 P580 Q113933570-B8989F41-0220-471F-8A6E-7F0613E8FAE8 @default.
- Q113933570 P582 Q113933570-63B4B421-6F99-42C5-B3F7-F88D2A145900 @default.
- Q113933570 P6099 Q113933570-5AD23E09-F95C-4628-84C1-BD211B95624D @default.
- Q113933570 P8005 Q113933570-B1765D5A-4488-41E7-A802-D26D43741BB7 @default.
- Q113933570 P8363 Q113933570-0D929B89-D0E0-46A9-B343-237DF55D451C @default.
- Q113933570 P1132 "+129" @default.
- Q113933570 P1476 "A Phase 1a/1b, Open-label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Anti-neoplastic Activity of S095029 (Anti-NKG2A) as Monotherapy and in Combination With Sym021 (Anti-PD-1) in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triplet Combinations of S095029 and Sym021 and an Anti-HER2 mAb or Anti-EGFR mAbs (Futuximab/Modotuximab) in Patients With Metastatic Gastric or Colorectal Cancers" @default.
- Q113933570 P17 Q16 @default.
- Q113933570 P17 Q30 @default.
- Q113933570 P2899 "+18" @default.
- Q113933570 P3098 "NCT05162755" @default.
- Q113933570 P31 Q30612 @default.
- Q113933570 P580 "2021-10-15T00:00:00Z" @default.
- Q113933570 P582 "2023-05-01T00:00:00Z" @default.
- Q113933570 P6099 Q5452194 @default.
- Q113933570 P8005 Q76649708 @default.
- Q113933570 P8363 Q78089383 @default.